These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
74 related articles for article (PubMed ID: 7851030)
1. Three cases of malignant hypertension: the roles of endothelin-1 and the renin-angiotensin-aldosterone system. Yoshida M; Nonoguchi H; Owada A; Ishiyama S; Maeda Y; Ando K; Iwamoto H; Shiigai T; Marumo F; Tomita K Clin Nephrol; 1994 Nov; 42(5):295-9. PubMed ID: 7851030 [TBL] [Abstract][Full Text] [Related]
2. The renin-angiotensin system in malignant hypertension revisited: plasma renin activity, microangiopathic hemolysis, and renal failure in malignant hypertension. van den Born BJ; Koopmans RP; van Montfrans GA Am J Hypertens; 2007 Aug; 20(8):900-6. PubMed ID: 17679041 [TBL] [Abstract][Full Text] [Related]
3. Lack of evidence for the interaction between renin-angiotensin-aldosterone system and endothelin in vivo. Widimský J; Dvoráková J; Hladovec J; Kopecká J Physiol Res; 1996; 45(3):241-3. PubMed ID: 9200216 [TBL] [Abstract][Full Text] [Related]
4. Genetic clamping of renin gene expression induces hypertension and elevation of intrarenal Ang II levels of graded severity in Cyp1a1-Ren2 transgenic rats. Mitchell KD; Bagatell SJ; Miller CS; Mouton CR; Seth DM; Mullins JJ J Renin Angiotensin Aldosterone Syst; 2006 Jun; 7(2):74-86. PubMed ID: 17083061 [TBL] [Abstract][Full Text] [Related]
5. Dissociation of selective renal venous plasma endothelin-1 activity and corresponding plasma renin activity in a patient with hypertension, severe stenosis of unilateral renal artery and ipsilaterally decreased renal function. Takeda M; Komeyama T; Katayama Y; Tsutsui T; Mizusawa T; Takahashi H; Go H; Tamaki M Nephron; 1994; 68(3):372-4. PubMed ID: 7838262 [TBL] [Abstract][Full Text] [Related]
6. Association studies suggest a key role for endothelin-1 in the pathogenesis of preeclampsia and the accompanying renin-angiotensin-aldosterone system suppression. Verdonk K; Saleh L; Lankhorst S; Smilde JE; van Ingen MM; Garrelds IM; Friesema EC; Russcher H; van den Meiracker AH; Visser W; Danser AH Hypertension; 2015 Jun; 65(6):1316-23. PubMed ID: 25870197 [TBL] [Abstract][Full Text] [Related]
7. Plasma renin activity and angiotensin I and aldosterone concentrations in cats with hypertension associated with chronic renal disease. Jensen J; Henik RA; Brownfield M; Armstrong J Am J Vet Res; 1997 May; 58(5):535-40. PubMed ID: 9140564 [TBL] [Abstract][Full Text] [Related]
8. Changes of blood pressure, plasma renin activity and plasma aldosterone concentration following the infusion of Sar1-Ile8-angiotensin II in hypertensive, fluid and electrolyte disorders. Yamamoto T; Doi K; Ogihara T; Ichihara K; Hata T; Kumahara Y Prog Biochem Pharmacol; 1976; 12():174-89. PubMed ID: 1019163 [TBL] [Abstract][Full Text] [Related]
9. The impaired control of plasma renin activity in hypertensive patients with end-stage renal disease due to chronic glomerulonephritis. Yasuda G; Nagasawa T; Umemura S; Shionoiri H; Ishii M Clin Nephrol; 1994 Nov; 42(5):300-8. PubMed ID: 7851031 [TBL] [Abstract][Full Text] [Related]
10. Urinary renin, but not angiotensinogen or aldosterone, reflects the renal renin-angiotensin-aldosterone system activity and the efficacy of renin-angiotensin-aldosterone system blockade in the kidney. van den Heuvel M; Batenburg WW; Jainandunsing S; Garrelds IM; van Gool JM; Feelders RA; van den Meiracker AH; Danser AH J Hypertens; 2011 Nov; 29(11):2147-55. PubMed ID: 21941204 [TBL] [Abstract][Full Text] [Related]
11. [Behavior of the plasma renin activity and aldosterone after salt restriction and upright posture in essential hypertension]. Kokot F; Kuska J; Chorqzy M Z Gesamte Inn Med; 1976 Dec; 31(24):1016-20. PubMed ID: 1020406 [TBL] [Abstract][Full Text] [Related]
12. Effect of NH4Cl acidosis on the function of renin-angiotensin-aldosterone system in newborn infants. Adamovich K; Sulyok E; Jaton T; Guignard JP J Dev Physiol; 1992 Jul; 18(1):9-12. PubMed ID: 1287079 [TBL] [Abstract][Full Text] [Related]
14. The renin-angiotensin-aldosterone system in primary and secondary hypertension. del Greco F; Huang CM; Quintanilla A; Krumlovsky F; Roxe DM; Santhanam S Ann Clin Lab Sci; 1981; 11(6):497-505. PubMed ID: 6119955 [TBL] [Abstract][Full Text] [Related]
15. [Effects of angiotensin converting enzyme inhibitor SQ 14,225 on the blood pressure, renin-angiotensin-aldosterone system and renal function in patients with malignant hypertension (author's transl)]. Shionoiri H; Uneda S; Tochikubo O; Ohonishi T; Harada J; Sesoko S; Goto E; Fujishima S; Kaneko Y Nihon Jinzo Gakkai Shi; 1980 Jan; 22(1):13-22. PubMed ID: 6247528 [No Abstract] [Full Text] [Related]
16. Negative association between plasma aldosterone concentration/plasma renin activity and morning blood pressure surge in never-treated hypertensive patients. Cho JS; Ihm SH; Jang SW; Chung WB; Choi YS; Shin DI; Seo SM; Park MW; Kim GH; Her SH; Kim CJ; Kim TH; Kang MK; Chang K; Park CS Clin Exp Hypertens; 2014; 36(4):195-9. PubMed ID: 24678899 [TBL] [Abstract][Full Text] [Related]
17. [Role of renin-angiotensin-aldosterone system in pathogenesis of arterial hypertension in chronic renal failure]. Lifshits NL; Kutyrina IM Ter Arkh; 1999; 71(6):64-7. PubMed ID: 10420461 [TBL] [Abstract][Full Text] [Related]
18. Normokalemic hyperaldosteronism in patients with resistant hypertension. Benchetrit S; Bernheim J; Podjarny E Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302 [TBL] [Abstract][Full Text] [Related]
19. Pathophysiology in malignant hypertension: with special reference to the renin-angiotensin system. Kawazoe N; Eto T; Abe I; Takishita S; Ueno M; Kobayashi K; Uezono K; Muratani H; Kimura Y; Tomita Y Clin Cardiol; 1987 Sep; 10(9):513-8. PubMed ID: 3621700 [TBL] [Abstract][Full Text] [Related]
20. [Pathophysiology and prognosis in malignant hypertension: comparison by underlying diseases]. Kawazoe N Fukuoka Igaku Zasshi; 1989 Oct; 80(10):467-76. PubMed ID: 2515135 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]